Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis

Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Alexander Domnich, Carlo-Simone Trombetta, Elettra Fallani, Marco Salvatore
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11684710/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis.
by: Alexander Domnich, et al.
Published: (2024-01-01)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
by: Alexander Domnich, et al.
Published: (2025-01-01)

Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45
by: Michael Pritsch, et al.
Published: (2016-01-01)

Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01)

Knowledge, Attitude, and Barriers Influencing Seasonal Influenza Vaccination Uptake
by: Mazin A. Barry, et al.
Published: (2020-01-01)

Optimal strategies of social distancing and vaccination against seasonal influenza
by: Eunha Shim
Published: (2013-07-01)

Differential Immunogenicity and Protective Efficacy Elicited by MTO- and DMT-Adjuvanted CMFO Subunit Vaccines against Mycobacterium tuberculosis Infection
by: Nadeem Ullah, et al.
Published: (2020-01-01)

PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies
by: John M. Hickey, et al.
Published: (2025-12-01)

Three Types of Broadly Reacting Antibodies against Influenza B Viruses Induced by Vaccination with Seasonal Influenza Viruses
by: Daisuke Hirano, et al.
Published: (2018-01-01)

Augmented immunogenicity of the HPV16 DNA vaccine via dual adjuvant approach: integration of CpG ODN into plasmid backbone and co-administration with IL-28B gene adjuvant
by: Yan Zhou, et al.
Published: (2025-01-01)

Seasonal Influenza Vaccination Uptake Among Australian Healthcare Professionals: An Archetype for Success
by: Caroline M. Hall, et al.
Published: (2025-01-01)

Critical assessment of uncertainty in economic evaluations on influenza vaccines for the elderly population in Spain
by: Raúl Ortiz-de-Lejarazu Leonardo, et al.
Published: (2025-02-01)

Autoimmune Hemolytic Anemia in a Renal Transplant Patient Following Seasonal Influenza Vaccination
by: Imran Gani, et al.
Published: (2019-01-01)

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context
by: Gabriela Tapia-Calle, et al.
Published: (2025-01-01)

Modelling seasonal influenza in Israel
by: Oren Barnea, et al.
Published: (2011-03-01)

The utility of preemptive mass influenza vaccination in controlling a SARS outbreak during flu season
by: Qingling Zeng, et al.
Published: (2007-07-01)

Vaccine oil adjuvants for the development of aquaculture
by: J. B. Arous, et al.
Published: (2018-04-01)

Adjuvants for peptide-based cancer vaccines
by: Willem W Overwijk, et al.
Published: (2016-09-01)

Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?
by: Iván Sanz-Muñoz, et al.
Published: (2025-02-01)

Dynamics Analysis of an Avian Influenza A (H7N9) Epidemic Model with Vaccination and Seasonality
by: Juping Zhang, et al.
Published: (2019-01-01)

Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
by: Toru Hirozane, et al.
Published: (2025-01-01)

COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS
by: S. A. Pokhvalny, et al.
Published: (2018-05-01)

Dependence of emulsion FMD vaccine immunogenicity on immune status of pigs
by: D. A. Lozovoy, et al.
Published: (2018-04-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
by: Erdal Eroglu, et al.
Published: (2016-01-01)

Low Seroconversion after One Dose of AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine in Solid-Organ Transplant Recipients
by: Mariangela R Resende, et al.
Published: (2013-01-01)

Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza in elderly Chinese patients with diabetes: A test-negative design case-control study
by: Zhengyan Chen, et al.
Published: (2025-12-01)

Enhanced Immunogenicity of Foot-and-Mouth Disease Virus-like Particles Using a Water-in-Oil-in-Water Adjuvant
by: Yujie Zhou, et al.
Published: (2024-12-01)

Immunogenicity and vaccine efficacy of Actinobacillus pleuropneumoniae-derived extracellular vesicles as a novel vaccine candidate
by: Su Hyun Park, et al.
Published: (2025-12-01)

Effectiveness of influenza vaccination in preventing confirmed influenza cases and hospitalizations in Northern Spain, 2023/24 season: A population-based test-negative case-control study
by: Iván Martínez-Baz, et al.
Published: (2025-02-01)

Physical layer security performance of MF relay selection systems
by: Ying CHENG, et al.
Published: (2021-09-01)

Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
by: Shi-Hsia Hwa, et al.
Published: (2013-11-01)

Prioritization of delayed vaccination for pandemic influenza
by: Eunha Shim
Published: (2010-12-01)

Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01)

Transcriptional Systems Vaccinology Approaches for Vaccine Adjuvant Profiling
by: Diogo Pellegrina, et al.
Published: (2025-01-01)

Randomized, observer-blind, controlled Phase 1 study of the safety and immunogenicity of the Na-GST-1/Alhydrogel hookworm vaccine with or without a CpG ODN adjuvant in hookworm-naïve adults.
by: David J Diemert, et al.
Published: (2024-12-01)

Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial
by: Siyue Jia, et al.
Published: (2025-12-01)

The influenza epidemic in Russia during the 2014–2015 season
by: Ludmila S. Karpova, et al.
Published: (2015-11-01)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01E vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
by: Ismaila Thera, et al.
Published: (2020-09-01)

Hero of the Soviet Union M.F. Кudatshkin (1923–2010)
by: I. A. Pavlenro
Published: (2012-08-01)